Chancery Cuts Attys' Fees In Celgene Director Pay Deal
A Delaware Chancery judge gave his stamp Wednesday to a deal that settles derivative claims over alleged excessive pay for directors of biopharmaceutical firm Celgene Corp., but said the claimed benefits...To view the full article, register now.
Already a subscriber? Click here to view full article